Browse by Uncontrolled Keywords
Number of items: 12.
A
Agak, GW;
Bejon, P;
Fegan, G;
Gicheru, N;
Villard, V;
Kajava, AV;
Marsh, K;
Corradin, G;
(2008)
Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya.
Vaccine, 26 (16).
pp. 1963-1971.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2008.02.020
Full text not available from this repository.
B
Boyle, MJ;
Wilson, DW;
Richards, JS;
Riglar, DT;
Tetteh, KKA;
Conway, DJ;
Ralph, SA;
Baum, J;
Beeson, JG;
(2010)
Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development.
Proceedings of the National Academy of Sciences of the United States of America, 107 (32).
pp. 14378-14383.
ISSN 0027-8424
DOI: https://doi.org/10.1073/pnas.1009198107
Full text not available from this repository.
H
Haque, A;
Chu, K;
Easton, A;
Stevens, MP;
Galyov, EE;
Atkins, T;
Titball, R;
Bancroft, GJ;
(2006)
A live experimental vaccine against Burkholderia pseudomallei elicits CD4(+) T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins.
The Journal of infectious diseases, 194 (9).
pp. 1241-1248.
ISSN 0022-1899
DOI: https://doi.org/10.1086/508217
Full text not available from this repository.
Hart, PJ;
O'Shaughnessy, CM;
Siggins, MK;
Bobat, S;
Kingsley, RA;
Goulding, DA;
Crump, JA;
Reyburn, H;
Micoli, F;
Dougan, G;
+2 more...
Cunningham, AF;
MacLennan, CA;
(2016)
Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
PloS one, 11 (1).
ISSN 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0145945
M
Mayor, A;
Aponte, JJ;
Fogg, C;
Saute, F;
Greenwood, B;
Dgedge, M;
Menendez, C;
Alonso, PL;
(2007)
The epidemiology of malaria in adults in a rural area of southern Mozambique.
Malaria journal, 6.
ISSN 1475-2875
DOI: https://doi.org/10.1186/1475-2875-6-3
Mordmuller, B;
Szywon, K;
Greutelaers, B;
Esen, M;
Mewono, L;
Treut, C;
Murbeth, RE;
Chilengi, R;
Noor, R;
Kilama, WL;
+9 more...
Imoukhuede, EB;
Imbault, N;
Leroy, O;
Theisen, M;
Jepsen, S;
Milligan, P;
Fendel, R;
Kremsner, PG;
Issifou, S;
(2010)
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon.
Vaccine, 28 (41).
pp. 6698-6703.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2010.07.085
Full text not available from this repository.
N
Noor, AM;
Mohamed, MB;
Mugyenyi, CK;
Osman, MA;
Guessod, HH;
Kabaria, CW;
Ahmed, IA;
Nyonda, M;
Cook, J;
Drakeley, CJ;
+2 more...
MacKinnon, MJ;
Snow, RW;
(2011)
Establishing the extent of malaria transmission and challenges facing pre-elimination in the Republic of Djibouti.
BMC infectious diseases, 11.
ISSN 1471-2334
DOI: https://doi.org/10.1186/1471-2334-11-121
R
Recker, M;
Bouma, MJ;
Bamford, P;
Gupta, S;
Dobson, AP;
(2009)
Assessing the burden of pregnancy-associated malaria under changing transmission settings.
Malaria journal, 8.
ISSN 1475-2875
DOI: https://doi.org/10.1186/1475-2875-8-245
S
Sirima, SB;
Nebie, I;
Ouedraogo, A;
Tiono, AB;
Konate, AT;
Gansane, A;
Derme, AI;
Diarra, A;
Ouedraogo, A;
Soulama, I;
+3 more...
Cuzzin-Ouattara, N;
Cousens, S;
Leroy, O;
(2007)
Safety and immtunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthethic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa.
Vaccine, 25 (14).
pp. 2723-2732.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2006.05.090
Full text not available from this repository.
Suwannasaen, D;
Mahawantung, J;
Chaowagul, W;
Limmathurotsakul, D;
Felgner, PL;
Davies, H;
Bancroft, GJ;
Titball, RW;
Lertmemongkolchai, G;
(2011)
Human Immune Responses to Burkholderia pseudomallei Characterized by Protein Microarray Analysis.
The Journal of infectious diseases, 203 (7).
pp. 1002-1011.
ISSN 0022-1899
DOI: https://doi.org/10.1093/infdis/jiq142
Full text not available from this repository.
V
van der Sande, MAB;
Mendy, M;
Waight, P;
Doherty, C;
McConkey, SJ;
Hall, AJ;
Whittle, HC;
(2007)
Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life.
Vaccine, 25 (8).
pp. 1509-1512.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2006.10.023
Full text not available from this repository.
W
White, MT;
Verity, R;
Griffin, JT;
Asante, KP;
Owusu-Agyei, S;
Greenwood, B;
Drakeley, C;
Gesase, S;
Lusingu, J;
Ansong, D;
+28 more...
Adjei, S;
Agbenyega, T;
Ogutu, B;
Otieno, L;
Otieno, W;
Agnandji, ST;
Lell, B;
Kremsner, P;
Hoffman, I;
Martinson, F;
Kamthunzu, P;
Tinto, H;
Valea, I;
Sorgho, H;
Oneko, M;
Otieno, K;
Hamel, MJ;
Salim, N;
Mtoro, A;
Abdulla, S;
Aide, P;
Sacarlal, J;
Aponte, JJ;
Njuguna, P;
Marsh, K;
Bejon, P;
Riley, EM;
Ghani, AC;
(2015)
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial.
The Lancet infectious diseases, 15 (12).
pp. 1450-1458.
ISSN 1473-3099
DOI: https://doi.org/10.1016/s1473-3099(15)00239-x